Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | PULM Pulmatrix, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $1.52 -2.4% | $16.31 +6.3% |
| StockIQ Score | 49D+ Moderate Risk: High | 42D Weak Risk: Medium |
| Technical | 43D | 36F |
| Fundamental | 46D+ | 35F |
| Growth | 66B- | 50C- |
| Fair Value | 50C- | 38F |
| News | 50C- | 50C- |
| Quality | 42D | 50C- |
| Risk | 40D | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Pulmatrix (PULM) outperforms Ascentage Pharma (AAPG) in most categories. Its investor score (49 vs. 42) and growth score (66 vs. 50) are notably higher, while AAPG has a weaker overall rating ("WEAK" vs. "MODERATE"). Fundamental and valuation scores are also better for PULM (46 vs. 35, 50 vs. 38). Technical scores favor PULM slightly (43 vs. 36).
